AI Market Mood: Stock Dashboard
IMNM
Fundamental
Company: Immunome Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -2.96
Insider Own: 9.94%
Shs Outstand: 110.33M
Perf Week: -3.48%
Market Cap: 2.35B
Forward P/E: -
EPS next Y: -2.59
Insider Trans: -2.83%
Shs Float: 99.37M
Perf Month: 15.43%
Enterprise Value: 2.08B
PEG: -
EPS next Q: -0.59
Inst Own: 79.93%
Short Float: 15.98%
Perf Quarter: 81.58%
Income: -222.74M
P/S: 242.36
EPS this Y: 55.57%
Inst Trans: 8.96%
Short Ratio: 8.48
Perf Half Y: 151.19%
Sales: 9.68M
P/B: 7.39
EPS next Y Percentage: -16.70%
ROA: -80.08%
Short Interest: 15.88M
Perf YTD: 100.22%
Book/sh: 2.88
P/C: 8.60
EPS next 5Y: 22.68%
ROE: -93.04%
52W High: 25.30 -15.96%
Perf Year: 91.56%
Cash/sh: 2.47
P/FCF: -
EPS past 3/5Y: -32.63% -38.15%
ROIC: -83.13%
52W Low: 5.15 312.87%
Perf 3Y: 577.17%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: 71.34%
Volatility W: 4.78%
Volatility M: 7.31%
Perf 5Y: 94.01%
Dividend TTM: -
EV/Sales: 214.61
EPS Y/Y TTM: 63.58%
Oper. Margin: -2137.10%
ATR (14): 1.44
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 8.90
Sales Y/Y TTM: -4.44%
Profit Margin: -2301.30%
RSI (14): 55.82
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 8.90
EPS Q/Q: 16.50%
SMA20: 3.14%
Beta: 2.24
Target Price: 34.25
Payout: -
Debt/Eq: 0.02
Sales Q/Q: -100.00%
SMA50: 15.64%
Rel Volume: 0.39
Prev Close: 21.60
Employees: 118
LT Debt/Eq: 0.02
Earnings: Nov 06 AMC
SMA200: 82.30%
Avg Volume: 1.87M
Price: 21.26
IPO: Oct 02, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: -14.94% -100.00%
Trades:
Volume: 236,247
Change: -1.56%
Technical:
Latest News:
Immunome to Present at 2024 Bank of America Healthcare Conference | Business Wire neutral
IMNM
Summary: Immunome, Inc. announced that its President and CEO will present at the Bank of America Healthcare Conference on May 15, 2024.
Full article2024-05-08T12:01:40Z